Drugs / S303 Red Blood Cells (RBCs)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01711346 | Oct 2012 → Jul 2014 | — | Cerus Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S303 Red Blood Cells (RBCs) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01711346 ↗ |
| Route | Intravenous | “one intravenous infusion of autologous radiolabeled S303 Red Blood Cells (RBCs)” NCT01711346 ↗ |